James C Blankenship
Overview
Explore the profile of James C Blankenship including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
5240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vazquez-Sosa C, Clegg S, Blankenship J
US Cardiol
. 2024 Dec;
15:e20.
PMID: 39720499
Percutaneous closure of a patent foramen ovale (PFO) reduces the risk of recurrent cryptogenic stroke specifically in younger patients. The three randomized controlled trials that led to the widespread adoption...
2.
Riangwiwat T, Blankenship J
US Cardiol
. 2024 Dec;
15:e04.
PMID: 39720496
Transradial access has been increasingly adopted for cardiac catheterization. It is crucial for operators to recognize potential vascular complications associated with radial artery access. Prevention, early detection, and prompt treatment...
3.
Azhar Y, Zabel K, Blankenship J
Coron Artery Dis
. 2024 Dec;
PMID: 39692460
Background: Mortality after percutaneous coronary intervention (PCI) remains a problem. Clinical databases such as the American College of Cardiology National Cardiovascular Data CathPCI Registry do not contain enough information to...
4.
Williams B, Blankenship J, Voyce S, Chang A
J Stroke Cerebrovasc Dis
. 2024 Oct;
33(12):108081.
PMID: 39396659
Objectives: Over the last decade, direct oral anticoagulants (DOAC) have become preferred over warfarin for stroke prevention in atrial fibrillation (AF). The objectives of this study were to quantify the...
5.
Millhuff A, Blankenship J
Cardiovasc Revasc Med
. 2024 Sep;
71:43-49.
PMID: 39343662
Introduction: Dual antiplatelet therapy (DAPT) with aspirin and a P2Y inhibitor is the standard of care for patients who undergo percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI)....
6.
Katukuri N, Blankenship J
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
3(6):102018.
PMID: 39132586
No abstract available.
7.
Grines C, Box L, Mamas M, Abbott J, Blankenship J, Carr J, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(2):100560.
PMID: 39129815
No abstract available.
8.
Alqam B, Blankenship J
Cardiovasc Drugs Ther
. 2024 Jul;
38(6):1091-1093.
PMID: 39009942
No abstract available.
9.
Boricha H, Blankenship J, Schade D
Cardiovasc Drugs Ther
. 2024 Jul;
38(6):1083-1087.
PMID: 38976144
Purpose: Statin drugs are effective at reducing cardiovascular events, but adherence to statin therapy remains a problem for patients and their physicians. We review a paper estimating the economic costs...
10.
Reddy R, Blankenship J
Cardiovasc Drugs Ther
. 2024 Jun;
38(6):1089-1090.
PMID: 38916837
No abstract available.